| |
Control (n=7) |
FS (n=7) |
p value |
| Tolerability |
5 |
3 |
0.59* |
| Reason for termination |
|
|
|
| |
New metastatic disease |
1 |
1 |
|
| |
Inability to tolerate muffin |
1 |
3 |
|
| Muffin ingestion (% of prescribed), mean (range) |
73 (8.5-100) |
37 (2.8-100) |
0.23** |
| Blood and urine collection time points, n |
|
|
|
| |
Pre-RT |
2 |
4 |
|
| |
Week 1 |
2 |
4 |
|
| |
End RT |
2 |
3 |
|
| |
1 mo post-RT |
2 |
2 |
|
| |
*P value calculation by Fisher's exact test (2-sided) |
|
|
*P value calculation by Fisher’s exact test (2-sided)
**P value calculation by Wilcoxon rank sum test |
